All Articles

A new survey reveals a deep communication crisis on the factory floor, costing billions in lost productivity, safety failures, and talent drain, and crippling AI adoption.

A new alliance between Scality and OVHcloud offers a sovereign, high-performance cloud for Europe's AI ambitions, directly answering regulatory demands.

Omnigo's new jail management system promises efficiency and safety. But can a software update solve deep-seated issues in our correctional facilities?

As AI scales enterprise-wide, risk management is being reinvented. LogicGate's new autonomous 'agents' promise to save thousands of hours and redefine compliance.

Following a $103M funding round, Kinaset Therapeutics adds proven dealmakers to its board, signaling a strategic push for its novel inhaled asthma therapy.

The latest from Sign In App turns static presence data into real-time, auditable action, offering a new level of safety, compliance, and peace of mind.

FreightWise's new BI tool gives SMB shippers data analytics once reserved for corporations, promising direct cost savings and smarter decisions.

Amperity's recent leadership nod from IDC highlights a critical truth: for AI to work, it needs trusted data. Here’s how this shift is redefining customer connection.

WattCycle's latest showcase reveals a major shift in Europe. Consumers now demand more than just power; they want smart, usable energy for balconies, RVs, and homes.

Orazio Buzza's win isn't just about food. It's about a tech-driven solution to the office culture crisis, powered by logistics, AI, and local restaurants.

With a near-total bond buyback, QXO has cleared a major financial hurdle in its massive TopBuild acquisition, paving the way for an industry-shaping merger.

A new rule allows Roth contributions in SIMPLE IRAs, a huge shift for small firms. Ascensus is an early adopter, but what does this really mean for workers?

As Richelieu Hardware preps its Q2 results, all eyes are on whether its growth strategy can defy North America's economic headwinds. A critical test.

New data reveals how Genelux’s oncolytic virus reawakens chemotherapy's power, offering a potential lifeline in a notoriously difficult-to-treat cancer.

An AI education firm and its investors allege a massive market manipulation scheme by Citadel and Virtu, turning a class action into a test case for fair markets.

A landmark deal to convert a vacant office tower into 512 affordable homes is just the start. How a new city ordinance and a strategic partnership are creating a blueprint to solve LA's dual crises.

With a new name, CEO, and a $1.2B revenue base, Circle8 is pivoting from staffing to a global tech powerhouse. Can its 'one-stop-shop' model win?

As energy becomes a critical boardroom issue for tech and manufacturing, PR firm MikeWorldWide hires Darrin Kayser to navigate the complex new landscape.

Allarity Therapeutics just secured a patent until 2042 for its cancer diagnostic. Is this the key to unlocking personalized treatment or a risky biotech bet?

Marga.ai's partnership with Eric Rozenberg promises an AI mentor with real judgment. But is digitizing expertise the future or a philosophical fallacy?